Submit Deal

IMMEDICA PHARMA AB

HQ - Stockholm

Summary

Immedica Pharma is a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 120 M

Avg. Deal Size£ 120 M

Market Context

Senior Management

Anders Edvell
CEO
Linda Holmström
Head of Communications
Benjamin Owens
EVP and Head of Corporate Development

Sort

23 Apr 2024|Sweden|Pharmaceuticals

Target: IMMEDICA PHARMA AB

Bidder: KKR & CO

24 Service Providers

4 Target | 13 Bidder | 7 Vendor

36 Dealmakers

2 Target | 8 Bidder | 26 Vendor

n/a

Value

30 Dec 2024|United States|Pharmaceuticals

Target: MARINUS PHARMACEUTICALS

Bidder: IMMEDICA PHARMA AB

8 Service Providers

4 Target | 4 Bidder

11 Dealmakers

6 Target | 5 Bidder

£ 120 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy